Search

Jay K Staas

from Madison, AL
Age ~67
Get Report
Also known as:
Jay Karl Staas, Jay R Staas, Jay K Stern
Phone and address:
104 Radisson Ln, Madison, AL 35758
(205) 515-5291
Related to:
Staas Whitney, 40Karl J Staas, 96Sandra P Staas, 65Leigh Lilly, 65Darius Parker, 44Lee D ParkerSteven K Staas, 71S MaccomasBonnie Emmerich-StaasStacey H Milwee, 61Ron Edmondson, 66Elloise V Staas, 92Whitney M Staas, 40Nicholas Staas, 37Robert G Milwee, 71
Connected to:
Donnette D Staas, 54Ellen E Staas, 35Lois A Staas, 70Sandra L Staas, 62Eric J Staat, 42Eugene G Staat, 69Jennie V Staat, 112Julie E Staat, 81Sharon A Staat, 80Shelly R Staat, 60

Jay Staas Phones & Addresses

  • 104 Radisson Ln, Madison, AL 35758 (205) 515-5291
  • 101 Ashford Ln, Alabaster, AL 35007 (205) 620-0902
  • Pelham, AL
  • 2141 Grande View Trl, Maylene, AL 35114 (205) 620-0902
  • Birmingham, AL
  • Huntsville, AL
  • Pinson, AL
  • Miami, FL

Work

Company: Jay staas consulting Jun 2009 Position: Pharmaceutical product development consultant

Education

Degree: Bachelors, Bachelor of Science School / High School: The University of Alabama In Huntsville 1977 to 1982 Specialities: Chemistry

Skills

Formulation • Gmp • Analytical Chemistry • R&D • Drug Development • Hplc • Drug Delivery • Fda • Encapsulation • Project Management • Lifesciences • Regulatory Submissions • Technology Transfer • Product Development • Validation • Glp • Pharmaceutics • Pharmaceutical Industry • Biotechnology

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Jay Staas Photo 1

Pharmaceutical Product Development Consultant

View page
Location:
104 Radisson Ln, Madison, AL 35758
Industry:
Pharmaceuticals
Work:
Jay Staas Consulting
Pharmaceutical Product Development Consultant
Surmodics Pharmaceuticals Aug 2007 - Mar 2009
Senior Director of Product Development
Brookwood Pharmaceuticals Jan 2005 - Aug 2007
Executive Director of Product Development
Southern Research Institute Apr 1, 1985 - Dec 1, 2004
Group Manager and Project Manager
Education:
The University of Alabama In Huntsville 1977 - 1982
Bachelors, Bachelor of Science, Chemistry Virgil I. Grissom High School
Skills:
Formulation
Gmp
Analytical Chemistry
R&D
Drug Development
Hplc
Drug Delivery
Fda
Encapsulation
Project Management
Lifesciences
Regulatory Submissions
Technology Transfer
Product Development
Validation
Glp
Pharmaceutics
Pharmaceutical Industry
Biotechnology
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jay Staas
Executive Director Of Product Development
Brookwood Pharmaceuticals Inc
Commercial Physical Research · Druggists' Goods Merchant Whols
756 Tom Martin Dr, Birmingham, AL 35211
(205) 917-2200, (205) 917-2205

Publications

Us Patents

Injectable Opioid Partial Agonist Or Opioid Antagonist Microparticle Compositions And Their Use In Reducing Consumption Of Abused Substances

View page
US Patent:
6495155, Dec 17, 2002
Filed:
Aug 25, 2000
Appl. No.:
09/648255
Inventors:
Thomas R. Tice - Birmingham AL
Jay K. Staas - Alabaster AL
Teresa M. Ferrell - Vestavia Hills AL
Peter Markland - Birmingham AL
Assignee:
Southern Research Institute - Birmingham AL
International Classification:
A61K 914
US Classification:
424426, 424423, 424489, 5147723, 514781, 514811, 514812, 514951, 514952
Abstract:
An injectable slow-release partial opioid agonist or opioid antagonist formulation is provided comprising a partial opioid agonist or opioid antagonist in a poly(D,L-lactide) excipient with a small amount of residual ethyl acetate. Upon intramuscular injection of the composition, a partial opioid agonist or opioid antagonist is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances. Of particular interest are the drugs buprenorphine, methadone and naltrexone.

Injectable Methadone, Methadone And Naltrexone, Or Buprenorphine And Naltrexone Microparticle Compositions And Their Use In Reducing Consumption Of Abused Substances

View page
US Patent:
7473431, Jan 6, 2009
Filed:
Dec 17, 2002
Appl. No.:
10/324062
Inventors:
Thomas R. Tice - Birmingham AL, US
Jay K. Staas - Alabaster AL, US
Teresa M. Ferrell - Vestavia Hills AL, US
Peter Markland - Birmingham AL, US
Assignee:
Brookwood Pharmaceuticals, Inc. - Birmingham AL
International Classification:
A61F 2/00
US Classification:
424426, 424425, 424424, 424497
Abstract:
An injectable slow-release methadone, partial opioid agonist or opioid antagonist formulation is provided comprising methadone, a partial opioid agonist or opioid antagonist in a poly(D,L-lactide) excipient with a small amount of residual ethyl acetate. Upon intramuscular or subcutaneous injection of the composition, methadone, a partial opioid agonist or opioid antagonist is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances. Of particular interest are the drugs buprenorphine, methadone and naltrexone.

Methods For Manufacturing Delivery Devices And Devices Thereof

View page
US Patent:
8541028, Sep 24, 2013
Filed:
Aug 3, 2005
Appl. No.:
11/196591
Inventors:
Jay K. Staas - Madison AL, US
Thomas R. Tice - Indian Springs AL, US
Bruce W. Hudson - Pleasant Grove AL, US
Arthur J. Tipton - Birmingham AL, US
Assignee:
Evonik Corporation - Parsippany NJ
International Classification:
A61K 9/14
US Classification:
424484
Abstract:
Described herein are methods for reducing and achieving the desired release of an agent from a delivery system. The desired release kinetics are achieved by exposing the surface of the delivery system with a fluid for a desired period of time.

Reduced-Mass, Long-Acting Dosage Forms

View page
US Patent:
20080305115, Dec 11, 2008
Filed:
Jun 9, 2008
Appl. No.:
12/157368
Inventors:
Thomas R. Tice - Indian Springs AL, US
Peter Markland - Birmingham AL, US
Jay K. Staas - Pelham AL, US
International Classification:
A61K 39/395
A61K 31/7088
US Classification:
4241581, 514 44, 4241301
Abstract:
Methods and compositions are disclosed whereby free antibody or nucleic acid co-administered with a long-acting formulation, such as a microparticle or implant, containing the antibody or nucleic acid to achieve a long duration of antibody or nucleic acid release. One result is that less of the long-acting formulation excipient or polymer is needed allowing for small-volume administrations as required, for example, for ocular, intra-dermal, orthopedic, brain and spinal delivery. In one aspect, the free antibody or nucleic acid alone has efficacy for an extended period, during which time, very little or no long-acting formulation antibody or nucleic acid is released. In one aspect, after the free antibody or nucleic acid has diminished activity, is gone, or no longer has activity, the long-acting formulation antibody or nucleic acid begins to release for a desired preprogrammed duration to provide long-acting durations. Less formulation mass is needed because the entire antibody or nucleic acid is not encapsulated or implanted with encapsulation or implant excipient or polymer. In addition, more antibody or nucleic acid can be administered to afford longer-acting formulations.

Methods Of Inducing Melanogenesis In A Subject

View page
US Patent:
20080305152, Dec 11, 2008
Filed:
Feb 11, 2005
Appl. No.:
11/659178
Inventors:
Michael John Kleinig - Victoria, AU
Thomas R. Tice - Indian Springs AL, US
Jay K. Staas - Maylene AL, US
Assignee:
CLINUVEL PHARMACEUTICALS LIMITED - MELBOURNE
International Classification:
A61K 9/70
A61K 38/08
A61K 38/10
A61K 9/48
A61K 9/14
A61K 9/00
A61K 9/10
A61K 9/127
A61K 38/12
US Classification:
424443, 514 14, 514 17, 514 16, 514 9, 514 15, 424450, 424455, 424484, 424489, 424422
Abstract:
Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.

Composition For Delivering Bioactive Agents For Immune Response And Its Preparation

View page
US Patent:
60249838, Feb 15, 2000
Filed:
Sep 7, 1993
Appl. No.:
8/116802
Inventors:
Thomas R. Tice - Birmingham AL
Richard M. Gilley - Birmingham AL
John H. Eldridge - Birmingham AL
Jay K. Staas - Birmingham AL
Assignee:
Southern Research Institute - Birmingham AL
The Uab Research Foundation - Birmingham AL
International Classification:
A61K 952
A61K 39085
A61K 3912
A61K 3939
US Classification:
424501
Abstract:
A method, and compositions for use therein capable, of delivering a bioactive agent to an animal entailing the steps of encapsulating effective amounts of the agent in a biocompatible excipient to form microcapsules having a size less than approximately ten micrometers and administering effective amounts of the microcapsules to the animal. A pulsatile response is obtained, as well as mucosal and systemic immunity.

Injectable Naltrexone Microsphere Compositions And Their Use In Reducing Consumption Of Heroin And Alcohol

View page
US Patent:
63064251, Oct 23, 2001
Filed:
Apr 7, 2000
Appl. No.:
9/545064
Inventors:
Thomas R. Tice - Birmingham AL
Jay K. Staas - Alabaster AL
Teresa M. Ferrell - Vestavia Hills AL
Assignee:
Southern Research Institute - Birmingham AL
International Classification:
A61F 200
A61K 900
A61K 914
A61K 4730
US Classification:
424426
Abstract:
An injectable slow-release naltrexone formulation is provided comprising naltrexone in a poly(D,L-lactide) matrix with a small amount of residual ethyl acetate. Upon intramuscular injection of the composition, naltrexone is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances.

Rapid Release Encapsulated Bioactive Agents For Inducing Or Potentiating An Immune Response And Methods Of Using Thereof

View page
US Patent:
63127318, Nov 6, 2001
Filed:
Aug 28, 1998
Appl. No.:
9/143162
Inventors:
Jay K. Staas - Alabaster AL
Thomas R. Tice - Birmingham AL
Syamal Raychaudhuri - Mercer Island WA
Paul R. Sleath - Seattle WA
Assignee:
Southern Research Institute - Birmingham AL
Corixa Corporation - Seattle WA
International Classification:
A61F 202
A61K 950
B32B 516
US Classification:
424501
Abstract:
A composition for inducing or potentiating an immune response, preferably a CTL, T helper cell, or neutralizing antibody response in a subject, comprising an antigen and/or a non-antigen bioactive agent capable of inducing or potentiating such an immune response encapsulated in a polymeric composition, wherein the polymeric composition comprises a blend of (a) a polymer present in an amount sufficient to provide structural integrity to the polymeric composition, and (b) a rapidly biodegradable component, a rapidly dissolving component, a rapidly swelling component, or a component that causes osmotic rupture of the encapsulated polymeric composition is disclosed. Single polymer compositions for achieving such an immune response are also disclosed. Methods for inducing or potentiating a CTL, T helper cell or neutralizing antibody response using the above-identified compositions are disclosed.
Control profile
Jay K Staas from Madison, AL, age ~67 Get Report